Vitura Health Limited

Informe acción ASX:VIT

Capitalización de mercado: AU$56.4m

Vitura Health Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Vitura Health ha aumentado sus beneficios a una tasa media anual de 58.2%, mientras que los beneficios de la industria de Pharmaceuticals han experimentado un crecimiento de 35.4% anual. Los ingresos han ido creciendo a una tasa media de 58.1% al año. La rentabilidad financiera de Vitura Health es de 8.5%, y sus márgenes netos son de 2.8%.

Información clave

58.2%

Tasa de crecimiento de los beneficios

96.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Pharmaceuticals 31.2%
Tasa de crecimiento de los ingresos58.1%
Rentabilidad financiera8.5%
Margen neto2.8%
Última actualización de beneficios30 Jun 2024

Actualizaciones de resultados anteriores recientes

Vitura Health's (ASX:VIT) Soft Earnings Don't Show The Whole Picture

Sep 07
Vitura Health's (ASX:VIT) Soft Earnings Don't Show The Whole Picture

Recent updates

There's No Escaping Vitura Health Limited's (ASX:VIT) Muted Revenues Despite A 33% Share Price Rise

Oct 17
There's No Escaping Vitura Health Limited's (ASX:VIT) Muted Revenues Despite A 33% Share Price Rise

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Oct 13
Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Vitura Health's (ASX:VIT) Soft Earnings Don't Show The Whole Picture

Sep 07
Vitura Health's (ASX:VIT) Soft Earnings Don't Show The Whole Picture

Vitura Health Limited's (ASX:VIT) 26% Dip In Price Shows Sentiment Is Matching Earnings

Aug 12
Vitura Health Limited's (ASX:VIT) 26% Dip In Price Shows Sentiment Is Matching Earnings

Vitura Health Limited (ASX:VIT) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Aug 12
Vitura Health Limited (ASX:VIT) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

The Market Doesn't Like What It Sees From Vitura Health Limited's (ASX:VIT) Earnings Yet As Shares Tumble 43%

Apr 25
The Market Doesn't Like What It Sees From Vitura Health Limited's (ASX:VIT) Earnings Yet As Shares Tumble 43%

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Apr 11
Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%

Feb 27
Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Feb 25
Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Calculating The Fair Value Of Vitura Health Limited (ASX:VIT)

Dec 13
Calculating The Fair Value Of Vitura Health Limited (ASX:VIT)

Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet

Nov 21
Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet

Is Now The Time To Put Vitura Health (ASX:VIT) On Your Watchlist?

Nov 01
Is Now The Time To Put Vitura Health (ASX:VIT) On Your Watchlist?

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Jul 18
Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Earnings Not Telling The Story For Cronos Australia Limited (ASX:CAU) After Shares Rise 111%

Sep 12
Earnings Not Telling The Story For Cronos Australia Limited (ASX:CAU) After Shares Rise 111%

If EPS Growth Is Important To You, Cronos Australia (ASX:CAU) Presents An Opportunity

Sep 05
If EPS Growth Is Important To You, Cronos Australia (ASX:CAU) Presents An Opportunity

Desglose de ingresos y gastos

Cómo gana y gasta dinero Vitura Health. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

ASX:VIT Ingresos, gastos y beneficios (AUD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Jun 241244290
31 Mar 241226270
31 Dec 231209250
30 Sep 2311912230
30 Jun 2311714200
31 Mar 2310712190
31 Dec 229710190
30 Sep 22828170
30 Jun 22676160
31 Mar 22545120
31 Dec 2142580
30 Sep 2132360
30 Jun 2122150
31 Mar 2115050
31 Dec 207-250
30 Sep 204-350
30 Jun 200-440
31 Mar 200-440
31 Dec 190-430
30 Sep 190-330
30 Jun 190-330
30 Jun 180000
30 Jun 170000

Ingresos de calidad: VIT tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(2.8%) de VIT son inferiores a los del año pasado (11.8%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: VIT ha pasado a ser rentable en los últimos 5 años, con un crecimiento de los beneficios de 58.2% al año.

Acelerando crecimiento: VIT ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: VIT tuvo un crecimiento negativo de los beneficios (-74.6%) durante el año pasado, lo que dificulta la comparación con la media de la industria Pharmaceuticals (46.5%).


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de VIT (8.5%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado